Category Archive for News Germany
News Germany – Health system, AMNOG, price negotiations, legal framework and how to navigate these successfully
Price moratorium remains in Germany
Since 2009, a price moratorium has been in place in Germany preventing the increase of some medicine prices. The annual … read more »
GKV-FKG Law passed to change competition between insurers
The Bundestag has approved the Law for fair health insurance competition in statutory health insurance to bring fairness to the … read more »
More detail emerges on Patient Data Protection Act
Germany’s Patientendaten-Schutzgesetz (Patient Data Protection Act) has continued its passage into law, and the Health Ministry has published a breakdown … read more »
IQWiG encourages use of registry data in assessment
The Institute for Quality and Efficiency in Health Care (IQWiG) explains that data from registries are appropriate for use in … read more »
German Emergency Care Reform Act proposed
Jens Spahn, Federal Minister of Health, has launched the Emergency Care Reform Act in hope of improving patients’ care when … read more »
The Dutch government removes Germany from its international reference pricing
The Rijksoverheid (Government of the Netherlands) has announced that Germany is no longer part of its international reference pricing basket. … read more »
GKV-FKG development: regulation to be enacted in spring 2020
The GKV-FKG – Gesetzliche Krankenversicherung Faire-Kassenwahl-Gesetz (Fair Health Insurance Law for the Statutory Health Insurance System) is expected to come … read more »
BPI Chief Executive: rebates lead to medicine shortages
The BPI – Bundesverband der Pharmazeutischen Industrie (The Federal Association of the Pharmaceutical Industry) has continued its criticism of the … read more »
G-BA and healthcare community call for tighter regulations of unlicensed high-cost medicines
The G-BA – The Gemeinsamer Bundesausschuss (Federal Joint Committee) and the wider healthcare community have called for stricter regulations of … read more »
BPI calls for more spending on Germany’s outpatient sector
Dr. Kai Joachimsen, the Chief Executive of BPI – Der Bundesverband der Pharmazeutischen Industrie (Federal Association of the Pharmaceutical Industry) … read more »
